Marian K Bakker

Summary

Affiliation: University Medical Center Groningen
Country: The Netherlands

Publications

  1. ncbi Selection of controls in case-control studies on maternal medication use and risk of birth defects
    Marian K Bakker
    EUROCAT Registration of Congenital Anomalies, Department of Genetics, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
    Birth Defects Res A Clin Mol Teratol 79:652-6. 2007
  2. ncbi First-trimester use of paroxetine and congenital heart defects: a population-based case-control study
    Marian K Bakker
    EUROCAT Northern Netherlands, Department of Genetics, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands
    Birth Defects Res A Clin Mol Teratol 88:94-100. 2010
  3. ncbi Fluoxetine and infantile hypertrophic pylorus stenosis: a signal from a birth defects-drug exposure surveillance study
    Marian K Bakker
    EUROCAT Northern Netherlands, Department of Genetics, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands
    Pharmacoepidemiol Drug Saf 19:808-13. 2010
  4. ncbi Increase in use of selective serotonin reuptake inhibitors in pregnancy during the last decade, a population-based cohort study from the Netherlands
    Marian K Bakker
    EUROCAT Registration of Congenital Anomalies, Department of Genetics, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands
    Br J Clin Pharmacol 65:600-6. 2008
  5. ncbi The role of maternal-fetal cholesterol transport in early fetal life: current insights
    Maria E Baardman
    EUROCAT Registration, Department of Genetics, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
    Biol Reprod 88:24. 2013
  6. ncbi Combined adverse effects of maternal smoking and high body mass index on heart development in offspring: evidence for interaction?
    Maria E Baardman
    EUROCAT Northern Netherlands, Department of Medical Genetics, University Medical Centre Groningen, PO Box 30001, 9700 RB Groningen, The Netherlands
    Heart 98:474-9. 2012
  7. ncbi Does folic acid use decrease the risk for spina bifida after in utero exposure to valproic acid?
    Janneke Jentink
    Pharmacoepidemiology and Pharmacoeconomics, SHARE, University of Groningen, The Netherlands
    Pharmacoepidemiol Drug Saf 19:803-7. 2010
  8. ncbi Survival and health in liveborn infants with transposition of great arteries--a population-based study
    Ester Garne
    Paediatric Department, Kolding Hospital, Kolding, Denmark
    Congenit Heart Dis 2:165-9. 2007

Collaborators

Detail Information

Publications8

  1. ncbi Selection of controls in case-control studies on maternal medication use and risk of birth defects
    Marian K Bakker
    EUROCAT Registration of Congenital Anomalies, Department of Genetics, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
    Birth Defects Res A Clin Mol Teratol 79:652-6. 2007
    ..The aim of this study is to investigate whether first trimester drug use among mothers of children with genetic disorders is representative for the "general pregnant population"...
  2. ncbi First-trimester use of paroxetine and congenital heart defects: a population-based case-control study
    Marian K Bakker
    EUROCAT Northern Netherlands, Department of Genetics, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands
    Birth Defects Res A Clin Mol Teratol 88:94-100. 2010
    ..There is a need for case-control studies of the effect of paroxetine on the occurrence of specific heart defects...
  3. ncbi Fluoxetine and infantile hypertrophic pylorus stenosis: a signal from a birth defects-drug exposure surveillance study
    Marian K Bakker
    EUROCAT Northern Netherlands, Department of Genetics, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands
    Pharmacoepidemiol Drug Saf 19:808-13. 2010
    ..We report an association found in a surveillance study which systematically evaluated combinations of specific birth defects and drugs used in the first trimester of pregnancy...
  4. ncbi Increase in use of selective serotonin reuptake inhibitors in pregnancy during the last decade, a population-based cohort study from the Netherlands
    Marian K Bakker
    EUROCAT Registration of Congenital Anomalies, Department of Genetics, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands
    Br J Clin Pharmacol 65:600-6. 2008
    ..However, the extent of SSRI use in pregnancy is largely unknown...
  5. ncbi The role of maternal-fetal cholesterol transport in early fetal life: current insights
    Maria E Baardman
    EUROCAT Registration, Department of Genetics, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
    Biol Reprod 88:24. 2013
    ....
  6. ncbi Combined adverse effects of maternal smoking and high body mass index on heart development in offspring: evidence for interaction?
    Maria E Baardman
    EUROCAT Northern Netherlands, Department of Medical Genetics, University Medical Centre Groningen, PO Box 30001, 9700 RB Groningen, The Netherlands
    Heart 98:474-9. 2012
    ..To study the influence of a possible interaction between maternal smoking and high body mass index (BMI) on the occurrence of specific congenital heart anomalies (CHA) in offspring...
  7. ncbi Does folic acid use decrease the risk for spina bifida after in utero exposure to valproic acid?
    Janneke Jentink
    Pharmacoepidemiology and Pharmacoeconomics, SHARE, University of Groningen, The Netherlands
    Pharmacoepidemiol Drug Saf 19:803-7. 2010
    ..However, there is less evidence for this protective effect in women using valproic acid (VPA). We investigated the effect of folic acid in women exposed to VPA in the first trimester of pregnancy...
  8. ncbi Survival and health in liveborn infants with transposition of great arteries--a population-based study
    Ester Garne
    Paediatric Department, Kolding Hospital, Kolding, Denmark
    Congenit Heart Dis 2:165-9. 2007
    ..To describe treatment, survival, and morbidity for liveborn infants with isolated transposition of great arteries (TGA)...